T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments.

PURPOSE To analyze T2 maps of pelvic and thigh muscles in Duchenne muscular dystrophy (DMD), to identify the most severely affected muscle, and to correlate the T2 of muscle with the grade of fatty infiltration at nonquantitative magnetic resonance (MR) imaging and results of clinical assessment. MATERIALS AND METHODS This prospective study was HIPAA compliant and was approved by the institutional review board; written consent was obtained from all participants' parents or guardians. Thirty-four boys with DMD (mean age, 8.4 years) were evaluated clinically (age, clinical function score, timed Gower score, time to run 30 feet, and serum creatine kinase [CK] level) and with nonquantitative MR imaging and axial T2 mapping from the iliac crest to the mid thigh. The T2 maps and mean T2 of 18 muscles in the pelvis and thighs were analyzed to identify the most severely involved muscle. The amount of fatty infiltration was assigned a grade of zero to four for all pelvic and thigh muscles by using T1-weighted nonquantitative MR images. The Spearman correlation coefficients model was used to correlate the mean T2, nonquantitative MR imaging score and clinical assessments. RESULTS The gluteus maximus muscle had the highest T2. The mean T2 for this muscle showed a significant correlation with the nonquantitative MR imaging score for fatty infiltration (P < .001) and with all clinical assessments except CK level. CONCLUSION Gluteus maximus muscles are most severely affected in patients with DMD. The T2 of the gluteus maximus muscle can be used as a quantitative and objective measure of disease severity.

[1]  Ivan Pedrosa,et al.  Body MRI using IDEAL. , 2008, AJR. American journal of roentgenology.

[2]  C. A. Peres,et al.  Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy , 1991, Journal of the Neurological Sciences.

[3]  J. Chamberlain,et al.  Gene therapy for muscular dystrophy – a review ofpromising progress , 2003, Expert opinion on biological therapy.

[4]  C. Swinyard,et al.  Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. , 1957, Archives of physical medicine and rehabilitation.

[5]  L. Ploutz-Snyder,et al.  Different effects of exercise and edema on T2 relaxation in skeletal muscle , 1997, Magnetic resonance in medicine.

[6]  V. Dubowitz,et al.  Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy , 1990, Journal of the Neurological Sciences.

[7]  Wilbur L. Smith,et al.  Magnetic resonance imaging of children with Duchenne muscular dystrophy , 2006, Pediatric Radiology.

[8]  K. Campbell,et al.  Contrast agent‐enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy , 2000, Magnetic resonance in medicine.

[9]  G. Fullerton,et al.  Proton magnetic resonance relaxation behavior of whole muscle with fatty inclusions. , 1985, Radiology.

[10]  Francesco Muntoni,et al.  Muscle MRI in inherited neuromuscular disorders: Past, present, and future , 2007, Journal of magnetic resonance imaging : JMRI.

[11]  Amanda C. Kight,et al.  Magnetic resonance imaging evaluation of the effects of juvenile rheumatoid arthritis on distal femoral weight-bearing cartilage. , 2004, Arthritis and rheumatism.

[12]  B. Goodpaster,et al.  Composition of Skeletal Muscle Evaluated with Computed Tomography , 2000, Annals of the New York Academy of Sciences.

[13]  G. Danieli,et al.  Duchenne muscular dystrophy. A population study. , 1977, Human genetics.

[14]  P. Law,et al.  Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. , 1992, Cell transplantation.

[15]  J. Strober,et al.  Therapeutics in Duchenne muscular dystrophy , 2006, NeuroRX.

[16]  G Sjøgaard,et al.  Extra- and intracellular water spaces in muscles of man at rest and with dynamic exercise. , 1982, The American journal of physiology.

[17]  B. Sjödin,et al.  Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies , 2000, The Journal of physiology.

[18]  M. Gutberlet,et al.  Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model. , 2009, Radiology.

[19]  D. Caudrey,et al.  PROGRESSION OF MUSCULAR DYSTROPHY ASSESSED BY COMPUTED TOMOGRAPHY , 1984, Developmental medicine and child neurology.

[20]  P Woo,et al.  Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. , 2004, Rheumatology.

[21]  A. Monaco Molecular human genetics and the Duchenne/Becker muscular dystrophy gene. , 1993, Molecular and cell biology of human diseases series.

[22]  R. Meyer,et al.  Pixel T2 distribution in functional magnetic resonance images of muscle. , 1999, Journal of applied physiology.

[23]  A. Connolly,et al.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging , 2005, Skeletal Radiology.

[24]  Vicente Gilsanz,et al.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. , 2008, AJR. American journal of roentgenology.

[25]  Van,et al.  Spatial variation of T2 in human articular cartilage. , 1997, Radiology.

[26]  T. Laor,et al.  Pediatric musculoskeletal MRI: basic principles to optimize success , 2008, Pediatric Radiology.

[27]  Hal B. Jenson,et al.  Nelson Textbook of Pediatrics , 1965 .

[28]  D. Skuk,et al.  Myoblast Transplantation in Whole Muscle of Nonhuman Primates , 2000, Journal of neuropathology and experimental neurology.

[29]  K. Davies Challenges in Duchenne muscular dystrophy 1 This review is based on the first Alan Emery lecture given at Green College, Oxford, on 11th March 1997. 1 , 1997, Neuromuscular Disorders.

[30]  G. Liu,et al.  Duchenne muscular dystrophy: MR grading system with functional correlation. , 1993, Radiology.

[31]  Carolynn Patten,et al.  T2 mapping of muscle. , 2003, Seminars in musculoskeletal radiology.

[32]  Vincent J Schmithorst,et al.  Mapping T2 relaxation time in the pediatric knee: feasibility with a clinical 1.5-T MR imaging system. , 2002, Radiology.

[33]  S. Majumdar,et al.  Quantitative MR relaxometry study of muscle composition and function in duchenne muscular dystrophy , 1994, Journal of magnetic resonance imaging : JMRI.

[34]  P. Law,et al.  Feasibility, Safety, and Efficacy of Myoblast Transfer Therapy on Duchenne Muscular Dystrophy Boys , 1992, Cell transplantation.

[35]  R. Ross,et al.  Skeletal muscle lipid concentration quantified by magnetic resonance imaging. , 2004, The American journal of clinical nutrition.

[36]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Birchall,et al.  MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. , 2007, Clinical radiology.

[38]  Stephan E Maier,et al.  Biexponential parameterization of diffusion and T2 relaxation decay curves in a rat muscle edema model: Decay curve components and water compartments , 2005, Magnetic resonance in medicine.

[39]  T. Helliwell,et al.  Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis , 1996, Muscle & nerve.

[40]  C. Angelini The role of corticosteroids in muscular dystrophy: A critical appraisal , 2007, Muscle & nerve.